Lionel Mandell

Summary

Affiliation: McMaster University
Country: Canada

Publications

  1. ncbi request reprint Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults
    Lionel A Mandell
    McMaster University, Hamilton, Ontario, Canada
    Clin Infect Dis 37:1405-33. 2003
  2. doi request reprint Doripenem: a new carbapenem in the treatment of nosocomial infection
    Lionel Mandell
    McMaster University Hamilton Health Sciences, 711 Concession St, Hamilton, Ontario, Canada
    Clin Infect Dis 49:S1-3. 2009
  3. ncbi request reprint Update on community-acquired pneumonia. New pathogens and new concepts in treatment
    Lionel A Mandell
    Division of Infectious Diseases, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada
    Postgrad Med 118:35-6, 41-6. 2005
  4. ncbi request reprint Epidemiology and etiology of community-acquired pneumonia
    Lionel A Mandell
    Division of Infectious Diseases, Department of Medicine, McMaster University, Henderson Site, 711 Concession Street, 40 Wing, 5th Floor, Room 503, Hamilton, ON Canada L8V 1C3
    Infect Dis Clin North Am 18:761-76, vii. 2004
  5. ncbi request reprint Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
    Lionel A Mandell
    McMaster University Medical School, Hamilton, Ontario, Canada
    Clin Infect Dis 44:S27-72. 2007
  6. ncbi request reprint Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia
    Lionel A Mandell
    McMaster University, Hamilton, Ontario, Canada
    Diagn Microbiol Infect Dis 44:127-8. 2002
  7. doi request reprint Spectrum of microbial etiology of community-acquired pneumonia in hospitalized patients: implications for selection of the population for enrollment in clinical trials
    Lionel A Mandell
    Div of Infectious Diseases, McMaster University Henderson Hospital, Hamilton, Ontario, Canada
    Clin Infect Dis 47:S189-92. 2008
  8. ncbi request reprint Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Tequin Clinical Experience Study (TeqCES)
    Lionel A Mandell
    McMaster University, Hamilton, Ontario, Canada
    Diagn Microbiol Infect Dis 44:65-7. 2002
  9. ncbi request reprint Medication options for the treatment of CAP
    Lionel A Mandell
    Am Fam Physician 74:1479. 2006
  10. ncbi request reprint Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study
    Thomas M File
    Northeastern Ohio Universities College of Medicine, Rootstown, OH and Summa Health System, 75 Arch Street, Suite 105, Akron, OH 44304, USA
    J Antimicrob Chemother 60:112-20. 2007

Detail Information

Publications19

  1. ncbi request reprint Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults
    Lionel A Mandell
    McMaster University, Hamilton, Ontario, Canada
    Clin Infect Dis 37:1405-33. 2003
  2. doi request reprint Doripenem: a new carbapenem in the treatment of nosocomial infection
    Lionel Mandell
    McMaster University Hamilton Health Sciences, 711 Concession St, Hamilton, Ontario, Canada
    Clin Infect Dis 49:S1-3. 2009
    ....
  3. ncbi request reprint Update on community-acquired pneumonia. New pathogens and new concepts in treatment
    Lionel A Mandell
    Division of Infectious Diseases, McMaster University Faculty of Health Sciences, Hamilton, Ontario, Canada
    Postgrad Med 118:35-6, 41-6. 2005
    ..He also explores monotherapy versus combination therapy, the efficacy of rapid initiation of treatment, and short-course therapy as a hedge against antimicrobial resistance...
  4. ncbi request reprint Epidemiology and etiology of community-acquired pneumonia
    Lionel A Mandell
    Division of Infectious Diseases, Department of Medicine, McMaster University, Henderson Site, 711 Concession Street, 40 Wing, 5th Floor, Room 503, Hamilton, ON Canada L8V 1C3
    Infect Dis Clin North Am 18:761-76, vii. 2004
    ..This article discusses the epidemiology and bacterial causes of CAP in immunocompetent adults and the severe acute respiratory syndrome coronavirus...
  5. ncbi request reprint Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
    Lionel A Mandell
    McMaster University Medical School, Hamilton, Ontario, Canada
    Clin Infect Dis 44:S27-72. 2007
  6. ncbi request reprint Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia
    Lionel A Mandell
    McMaster University, Hamilton, Ontario, Canada
    Diagn Microbiol Infect Dis 44:127-8. 2002
  7. doi request reprint Spectrum of microbial etiology of community-acquired pneumonia in hospitalized patients: implications for selection of the population for enrollment in clinical trials
    Lionel A Mandell
    Div of Infectious Diseases, McMaster University Henderson Hospital, Hamilton, Ontario, Canada
    Clin Infect Dis 47:S189-92. 2008
    ..Stratification by site takes into account local epidemiology and can balance differences in unmeasured confounders among sites...
  8. ncbi request reprint Safety and efficacy of gatifloxacin in community-acquired pneumonia: rationale for the Tequin Clinical Experience Study (TeqCES)
    Lionel A Mandell
    McMaster University, Hamilton, Ontario, Canada
    Diagn Microbiol Infect Dis 44:65-7. 2002
  9. ncbi request reprint Medication options for the treatment of CAP
    Lionel A Mandell
    Am Fam Physician 74:1479. 2006
  10. ncbi request reprint Gemifloxacin once daily for 5 days versus 7 days for the treatment of community-acquired pneumonia: a randomized, multicentre, double-blind study
    Thomas M File
    Northeastern Ohio Universities College of Medicine, Rootstown, OH and Summa Health System, 75 Arch Street, Suite 105, Akron, OH 44304, USA
    J Antimicrob Chemother 60:112-20. 2007
    ..Short-course therapy has been advocated for the treatment of community-acquired pneumonia (CAP). We compared the efficacy and safety of 5 and 7 day courses of gemifloxacin for outpatient treatment of mild-moderate CAP...
  11. ncbi request reprint Antimicrobial resistance and treatment of community-acquired pneumonia
    Lionel A Mandell
    Division of Infectious Diseases, McMaster University, Henderson Site, 711 Concession Street, 40 Wing, 5th Floor, Room 503, Hamilton, Ontario L8V 1C3, Canada
    Clin Chest Med 26:57-64. 2005
    ..The discussion is limited to infection with Streptococcus pneumoniae and to the treatment of patients hospitalized in a medical ward or an intensive care unit because of pneumococcal CAP...
  12. ncbi request reprint Meta-analysis of bacterial resistance to macrolides
    Michael T Halpern
    Exponent, Inc, 1800 Diagonal Road, Suite 300, Alexandria, VA 22314, USA
    J Antimicrob Chemother 55:748-57. 2005
    ..This meta-analysis systematically evaluated resistance of Streptococcus pneumoniae and Streptococcus pyogenes to macrolide antibiotics among patients with community-acquired respiratory tract infections...
  13. ncbi request reprint Comparative efficacies and tolerabilities of intravenous azithromycin plus ceftriaxone and intravenous levofloxacin with step-down oral therapy for hospitalized patients with moderate to severe community-acquired pneumonia
    Marcus Zervos
    William Beaumont Hospital, Royal Oak, Michigan, USA
    Treat Respir Med 3:329-36. 2004
    ..To compare the efficacy and tolerability of ceftriaxone plus azithromycin with those of levofloxacin in the treatment of hospitalized patients with moderate to severe community-acquired pneumonia (CAP)...
  14. ncbi request reprint Short-course treatment of community-acquired pneumonia
    Lionel A Mandell
    Clin Infect Dis 37:761-3. 2003
  15. ncbi request reprint What is optimal antimicrobial therapy for bacteremic pneumococcal pneumonia?
    Thomas M File
    Clin Infect Dis 36:396-8. 2003
  16. ncbi request reprint Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae
    Ronald N Jones
    The JONES Group JMI Laboratories, North Liberty, Iowa, USA
    Diagn Microbiol Infect Dis 44:93-100. 2002
    ..These results support recommendations to treat CAP, particularly due to S. pneumoniae including multidrug-resistant strains, with the newer 8-methoxy-fluoroquinolone, gatifloxacin...
  17. ncbi request reprint Fluoroquinolones for the treatment of outpatient community-acquired pneumonia
    Ronald N Jones
    The JONES Group JMI Laboratories, North Liberty, Iowa, USA
    Diagn Microbiol Infect Dis 44:69-76. 2002
    ..This overview of the fluoroquinolones directs particular attention to use in community-acquired pneumonia and safety...
  18. ncbi request reprint The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?
    Lionel A Mandell
    Division of Infectious Diseases, McMaster University School of Medicine, Hamilton, Ontario, Canada
    Clin Infect Dis 35:721-7. 2002
    ....
  19. ncbi request reprint Etiologies of acute respiratory tract infections
    Lionel A Mandell
    Clin Infect Dis 41:503-6. 2005